---
schema_version: "secwatch.filing_event.v1"
accession: "0001641489-23-000074"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2023-11-15T23:59:59+00:00"
generated_at: "2026-06-08T02:29:01.890619+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# vTv Therapeutics posts updated investor presentation; no specific financial updates disclosed in filing text.

## Summary
- Presentation posted on November 15, 2023, will be used in meetings with investors and analysts.
- Filing provides no details on financials, pipeline progress, or guidance changes.
- Exhibit content is not fully reproduced; materiality cannot be assessed from filing alone.

## SEC filing metadata
- accession: 0001641489-23-000074
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2023-11-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000074/0001641489-23-000074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000074/vtvt-20231115.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641489-23-000074
- JSON: https://secwatch.observer/filing/0001641489-23-000074.json
- Plain text: https://secwatch.observer/filing/0001641489-23-000074.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.